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SupasulfasAbstract What would have happened had Alexander Fleming not discovered penicillin in 1928?
Perhaps the obvious answer is that, someone else would have discovered penicillin during 1930s
and the Oxford group, would still have puriﬁed it sometime in the early 1940s. Here, however, in
this counterfactual account of the penicillin story, it is argued that without Fleming, penicillin might
still be undiscovered and the antibiotic age would never have dawned. As a result, many of the
recent developments in medicine, such as organ transplantation, might have been delayed or, at
best, made more hazardous. Penicillin might have come onto the scene a few years later but, had
Fleming overlooked the discovery, it seems certain that penicillin would not have saved countless
Allied lives, during and after D-Day. Instead of having enjoyed ﬁfty and more years of the antibi-
otic age, it is argued here, that we would have had to rely upon highly developed sulphonamides, so-
called ‘‘supasulfas’’, and other chemically-derived antibacterial drugs. Indeed, it might be the case
that, even well into this new millennium, the antibiotic age has yet to dawn, and medicine is still
waiting for someone to chance upon penicillin. Here we discuss what might have happened had
Fleming not discovered penicillin and come to the conclusion that the medical armoury available
today would have been far different and might have relied solely upon highly developed varieties
of sulphonamides or similar, synthetic, non-antibiotic antibacterial agents.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.
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It is September, 1928; a forty-seven year old man walks, some-
what wearily, up the steps to his place of work. He would
rather not be there. Summer is not yet over and he has had
to return to London because of an emergency, otherwise he
would still be enjoying life at his rural cottage in Suffolk. On
entering his room, one of his assistants exchanges pleasantries
and he doubtless responds with a few mild curses. The man sits
at the bench; he is a scientist and this is his laboratory. Casu-
ally, he picks up a few old petri dishes on which he has been
growing bacteria. He glances through them until he comes to
one that looks unusual. A colony of mould has somehow
found its way into the dish and is dissolving the bacteria
around it. He shows the unusual plate to his assistant who
shows only mild interest and then hands it back without com-
ment. The scientist has one last casual look, decides the phe-
nomenon is of no importance, and drops the dish into a
bucket of disinfectant. Our scientist then picks up his bag
and hurries off to catch the train back to Suffolk, unaware that
he has just thrown away the opportunity to save millions of
lives, win a Nobel Prize and become one of the most famous
and feted men in history.
The above is of course a counter-factual account of how
Alexander Fleming failed to discover penicillin, the standard
story having been given many times elsewhere (Diggins,
1999; Garrod, 1947; Hare, 1982; Lignam, 2000; Wainwright
and Swan, 1986; Wainwright, 1987, 1990, 2008).
Andrew Roberts, in the introduction to What Might Have
Been, a book devoted to counterfactual studies, suggests that
while battles, and many other events in history, can be success-
fully studied from a counterfactual perspective, the exposure of
scientiﬁc discoveries to such a process tends to be less success-
ful (Roberts, 2004). This is simply because, it is generally
assumed, that if a scientist misses a discovery then sooner or
later someone else will get there; gravity for example, would
have still be open to discovery had Sir Isaac Newton never seen
an apple tree!. However, here I wish to suggest that had Flem-
ing not discovered penicillin then it is likely that, the ﬁrst and
most important of the antibiotics would remain undiscovered.
There would also have been various time-related conse-
quences; notably, insufﬁcient penicillin would have been avail-
able for use by the Allies from D-Day onwards and other
antibiotics (notably, the anti-TB drug, streptomycin) might
never have been developed in time to back a number of major
developments in modern surgery such as open heart and trans-
plant surgery.
But, if Fleming had missed his chance, surely someone else
would have discovered penicillin? Possibly, but it should be
remembered that penicillin, although discovered by Fleming
in 1928, was not puriﬁed and developed for medicine until
the early 1940s, and there is no reason to believe that anyone
was close to discovering penicillin in the interim. At best, with-
out Fleming’s discovery penicillin would have languished for
perhaps another ﬁve or ten years.Let us begin our counterfactual journey by going back to
that fateful moment in September, 1928 when Fleming missed
the opportunity to discover penicillin. . .what happened next?
Has as we have seen, although Fleming discovered penicil-
lin in 1928 and wrote his ﬁrst penicillin paper in 1929, the drug
was not made available for medical use (and then largely
restricted to the military) until the early nineteen forties, fol-
lowing the intervention of Florey, Chain and co-workers at
the Oxford University. Of course penicillin could have been
discovered the day after Fleming missed the opportunity, but
in reality there was no parallel discovery took place. As a
result, anyone taking an interest in penicillin during the
1930s did so in the knowledge of Fleming’s work. In particu-
lar, there seems no reason to believe that Florey and Chain
would have discovered penicillin, since their work depended
on Fleming’s famous paper and their access to one of his pen-
icillin-producing cultures.
Since penicillin was, in reality, not available during the
1930s few events and lives would have been materially altered
if Fleming had missed the discovery. Fleming’s ﬁrst penicillin
paper refers to its use as an additives to bacteriological media
to selectively isolate the bacterium Bacillus inﬂuenzae, then
thought to cause inﬂuenza. A couple of workers reported using
penicillin in this way, but their work was far from earth shat-
tering, and the world of medicine would have happily contin-
ued without it. Similarly, without Fleming’s discovery an
American student, called Roger Reid, would have needed to
ﬁnd another research topic for his MS thesis; no doubt his
supervisor would have come up with another topic and the
young man’s career would not have suffered unduly.
The absence of penicillin in the 1930s would however, have
had more serious consequences for the lives of three people liv-
ing in the steel city of Shefﬁeld in England, who beneﬁted from
treatment with penicillin-rich ﬁltrates. In 1930 such ﬁltrates
were used by Cecil George Paine to cure infections which
might have left the children blind. Paine had worked in Flem-
ing’s laboratory (and had seen the famous plate). On graduat-
ing, he left London to work in Shefﬁeld. This, his ﬁrst job, was
described as being conjoint, that is his efforts were to be
divided acting as a Pathologist at the Royal Inﬁrmary and lec-
turing at the nearby Shefﬁeld University. The young man, was
required to do some research and remembering the penicillin
plate, he obtained a culture of the penicillin-producing mould
from Fleming. This, he cultured and used penicillin-rich ﬁl-
trates to treat infections. His ﬁrst attempts, against the skin
infection sychosis barbae were unsuccessful, so he turned his
attention to eye infections, arguing that the penicillin ﬁltrates
would be more likely to reach pathogens in the eye, than in
puss-rich skin infections. Paine treated three eye patients, a
local coal miner, whose eye had become infected after an acci-
dent, and two new born babies. All the infections were cured
by the simple act of irrigating the infected eye with mould ﬁl-
trates. The two babies were suffering from ophthalmia neona-
torum caused by Gonococcus and diphtheroids. Such infections
in the new-born were common before the advent of puriﬁed
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infections were permanently blinded; by using penicillin, Paine
therefore, potentially, saved the eyesight of all three of his
patients. Unfortunately, Paine never published his work and
penicillin continued to languish until 1939, when the Oxford
workers began to take an interest in it.
Contrary to what is often said, Fleming did not lose interest
in penicillin in the 1930s but continued working on it until
almost the point when the Oxford Group began their work,
but except for Paine’s, unpublished work, the existence of pen-
icillin at this time had no impact whatsoever on medicine.
What then might have happened next? Would penicillin
have remained undiscovered, or would someone else have
chanced upon it, perhaps by a less serendipitous route that fate
offered Fleming.
The ﬁrst obvious question is – would the Oxford Group
have discovered penicillin without Fleming’s intervention?
The answer is – most probably not. The Oxford workers
became interested in penicillin when Ernst Chain began to
search the literature on naturally occurring antibacterial
agents. After an extensive literature search, Chain concen-
trated on three potentially useful substances, an agent pro-
duced by B. subtilis, another bacterial agent called
pyocyanase and (after reading Fleming’s paper) penicillin.
He began with an abortive study of pyocyanase but soon
turned his attention to penicillin. Amazingly, a culture of
Fleming’s mould was already kept at Oxford enabling Chain
to make an immediate start on the puriﬁcation of penicillin.
The rest is history penicillin was puriﬁed and, with American
help, eventually produced in vast quantities, sufﬁcient to help
the Allies win the War. Without Fleming’s discovery Chain
would have never chanced upon his paper and began his work
on penicillin.
Florey was aware of penicillin from its inception. He had
been on editorial board of the British Journal of Experimental
Pathology which accepted Fleming’s paper and, because of his
background, probably reviewed the paper. Paine also informed
him about his therapeutic success with crude penicillin while he
was the Professor at Shefﬁeld University. Even with this back-
ground however, Florey seems never to have insisted that
Chain initially concentrated on penicillin.
Was anyone else close to discovering penicillin as the dec-
ade of 1940s began? The simple answer is No. An American
scientist named Bornstein provided a non-clinical paper on
penicillin in 1940 and it has also been suggested that an Amer-
ican pharmaceutical company took an interest around the
same time. However, both of these were developments based
on Fleming’s discovery.
During the late 1930s however, a potentially important
breakthrough in the development of antibacterial agents did
occur with the discovery, by Rene Dubois, of gramicidin
(Hotchkiss, 1990). Dubois found that a soil bacterium could
produce bactericidal extracts from which was obtained the
antibiotics gramicidin and tyrothricin. Unfortunately both
compounds were found to be toxic and cannot be given intra-
venously; not surprisingly, their medical use is limited as top-
ical antibacterial agents.
One might imagine that the discovery of gramicidin, despite
its limitations, would have induced individuals and pharma-
ceutical companies to begin systematic searches for antibi-
otic–producing microorganisms that would inevitably have
led to penicillin. Surprisingly however, such searches nevermaterialised until after penicillin was introduced into medicine
(Bennett and Chung, 2001).
Might other antibiotics have been discovered had penicil-
lin not been discovered in 1928? To answer this question we
have to consider the work of the Rutgers soil microbiologist,
Selman Waksman. Waksman’s work was pivotal in the devel-
opment of the post-penicillin antibiotics. As early as 1937, he
reported studies on antagonism between soil microorganisms,
and in 1940 he published a paper on the soil as a source of
microbes capable of antagonising the growth of human path-
ogenic bacteria. Surprisingly however, none of this work
relates to the production of antibiotics (a term indecently
coined by Waksman), but instead it was concerned with the
factors inﬂuencing the survival of a pathogenic bacteria in
soils. Eventually however, Waksman and his co-workers did
begin a systematic search for antibiotic which gave us a num-
ber of antibiotics, most notably the anti-TB compound, strep-
tomycin. Waksman was heralded as the ‘‘the father of the
antibiotics’’, but what induced him to begin a searching
for antibiotics? The answer is penicillin; without which,
Waksman would never have begun his search for novel anti-
biotics. We know this to be true, because Waksman said that
his decision to search for antibiotics (notably from a group of
bacteria called actinomycetes) resulted from seeing what
‘‘these English scientists are doing with penicillin.’’ So, no
Fleming, no penicillin – no work on penicillin by the Oxford
Group and no antibiotics (including streptomycin) from
Waksman’s laboratory.
The most important consequence of this counter historical
chain of events then would have been the absence of strepto-
mycin, an antibiotic which, when used with PAS, was the ﬁrst
effective treatment for tuberculosis. Without streptomycin, TB
would have continued to have been a major scourge through-
out 1940s and 1950s.
One person whose life would have been altered in a major
way, had streptomycin never appeared would have been its
co-discovery, and one of Waksman’s PhD students, Albert
Schatz. Schatz was the senior author on the ﬁrst streptomycin
paper, and despite being legally deﬁned as co-discoverer, did
not share in the Nobel Prize for streptomycin which was given
to Waksman alone. In order to win credit for his role in the
discovery of streptomycin and a share in the royalties, Schatz
had to take legal action against the Waksman and Rutgers
University. Although successful, the US academic establish-
ment began to see him a troublemaker and he was effectively
ostracised from American academia. Without streptomycin
Schatz would doubtless have been poorer and less notorious,
but would have probably obtained a PhD in some other aspect
of microbiology. Doubtless he would have gone on to a pro-
ductive academic life, devoting himself to his ﬁrst love, soil
microbiology.
So without Fleming penicillin, and the other antibiotics
now in a wide use, might never have been discovered. Would
we then be totally at the mercy of disease? Fortunately not,
because there came into use a class of drugs that would have
provided an, albeit imperfect, alternative to the antibiotics.
These compounds were the sulphonamides, or sulpha drugs,
which although antibacterial, are not strictly antibiotics, (by
deﬁnition an antibiotic must be made by microorganisms, or
at the very least by living things).
The sulphonamides are however, relatively effective anti-
bacterial agents and continue to be used in modern medicine
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medicine during the mid 1930s and immediately had a major
impact on the treatment of bacterial infections, most notably
septicemia and childbed fever. Alexander Fleming spent con-
siderable time during the mid-1930s researching this com-
pound. When they ﬁrst came into use they appeared
miraculous, but of course they were soon eclipsed by penicillin
and subsequent antibiotics. Had the golden age of antibiotics
never happened then the sulphonamides would inevitably have
been used more widely. No doubt more effective derivatives
would have been found (what we might call ‘‘supasulfurs’’);
these compounds might equalled or even bettered the antibiot-
ics. It is noteworthy that a major compendium of the use
of antibiotics says this about the clinical use of the
sulphonamides:
‘‘There are now very few speciﬁc indications for sulfona-
mides, because of the wide range of available antibiotics’’.
Clearly the situation might have been different if there were
no antibiotics to fall back on. The development of ‘‘supasul-
phas’’ might even have prevented the development of the anti-
biotics during the say in 1960s, since the pharmaceutical
industry might have argued that the sulphonamides were doing
the job and there was little need to invest large amounts of cap-
ital and expertise was needed to extract antibacterial agents
from messy mould juices. It is interesting to look back and
see in what regard the sulphonamides were held, even as
1947, when the medial bacteriologist L.P. Garrod made some
counter historical comments of his own. In reviews of Master’s
book, Garrod pondered on what might have happened had
penicillin been puriﬁed in 1930 and commented it would have
meant that the sulphonamides would probably never have
appeared, a possibility that he suggested would have ‘‘rendered
the world as a whole poorer.’’ However, had a commitment
been made around this time to antibiotic discovery and pro-
duction developments in biotechnology would have been such
that these compounds would have been rapidly developed
from discovery, through puriﬁcation to large-scale production.
Conversely the pharmaceutical industry would not have been
able to rely upon the vast amount of Government funding
and critical sense of wartime urgency that gave us penicillin
in 1940s.
The axis powers fought the Second World War without
penicillin, instead relying upon the sulpha drugs. Despite the
fact that the Germans and their Allies were at a considerable
disadvantage, the sulphonamides did a relatively good job at
reducing battle casualties. There is no doubt however, that,
without penicillin, Allied casualties from D-Day onwards
would have been far greater than they were. This brings us
to, yet another, interesting scenario. There is evidence to sug-
gest that Hitler’s doctor used penicillin to treat the Fuhrer
after the Staffenberg assassination attempt of 20th July, 1944
(Wainwright, 2004). Without this treatment, Hitler might have
died and the Germans might then have sued for peace a likeli-
hood that takes us into a yet more complex realm of counter-
factual speculation. Interestingly, the sulphonamides saved
Churchill’s life when he suffered from pneumonia in Cairo in
1943. What would have happened in a world that, from 1942
onwards, in which the pivotal ﬁgure of Winston Churchill
was absent?What effect would Fleming’s failure to discover penicillin
have had on the lives of the major ﬁgures involved in antibiot-
ics era? Undoubtedly, all of the major players would (had they
not made an unconnected, major discovery) have been forgot-
ten and none of them would have received knighthoods, Nobel
Prizes, or the other accolades that were showered upon them.
Instead these accolades might have fallen to Gerard Domagk
and the unknown pioneers who might later have developed
the ‘‘supasulfas’’. Doubtless Domagk would have been the
subject of numerous biographies and TV documentaries, and
children’s books, would simply relate the story of how the
Nazis prevented him from accepting the Nobel Prize for Phys-
iology and Medicine.
It is often automatically assumed that had Fleming not dis-
covered penicillin then someone else would have. This could
obviously have happened, but probably not in time to enable
penicillin to save so many Allied lives from D-Day onwards.
While the view that the sulphonamides would have successfully
replaced the antibiotics is debatable, it is certain that we would
be facing the same problems with sulphonamide, resistance as
we are with antibiotic resistance.
Alexander Fleming is often criticised for not being more
pro-active in developing penicillin as a curative agent. Interest-
ingly, it has recently come to light that a research grant was
made to the UK Medical Research Council, as early as 1930
for Stuart Craddock, one of Fleming’s assistants who, during
this period, worked on penicillin. The request was refused,
and the page detailing the proposed grant has mysteriously
been excised from, the otherwise complete, MRC records.
Maybe someone was keen to avoid the ridicule for having
refused to support the work that would possibly have made
penicillin available a decade sooner. Perhaps the perpetrator
of this academic crime should have relaxed, since it is unlikely
that penicillin could have been produced, on an industrial
scale, during the early 1930s and had it been so, then the axis
powers could have shared its beneﬁts during the Second World
War.
In conclusion, why not take this fantasy even further? It is
June of 2013, a microbiologist with a lifetime’s experience of
growing fungi and bacteria enters his university and picks up
a contaminated petri dish.
‘‘That’s funny!’’ he says.
This is how ‘‘Professor X’’ came to discover penicillin
towards the end of the ﬁrst decade of the new millennium.
Unfortunately, his discovery will probably come to nothing.
Why would anyone be interested in the expensive development
of this new antibacterial agent? Might the consensus be -We
have the supersulfas, what could possibly beat them? Why
should anyone waste time and money trying to purify some
messy mould juice? Stick to the supersulfas, that is where the
future of medicine lies.
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